0000899243-18-003274.txt : 20180208 0000899243-18-003274.hdr.sgml : 20180208 20180208160550 ACCESSION NUMBER: 0000899243-18-003274 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20180208 DATE AS OF CHANGE: 20180208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Merck Global Health Innovation Fund, LLC CENTRAL INDEX KEY: 0001547132 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37367 FILM NUMBER: 18585789 BUSINESS ADDRESS: STREET 1: ONE MERCK DRIVE CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: ONE MERCK DRIVE CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Merck Sharp & Dohme Corp. CENTRAL INDEX KEY: 0000942443 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37367 FILM NUMBER: 18585790 BUSINESS ADDRESS: STREET 1: ONE MERCK DRIVE CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: ONE MERCK DRIVE CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889 FORMER NAME: FORMER CONFORMED NAME: SCHERING CORP DATE OF NAME CHANGE: 19950321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37367 FILM NUMBER: 18585788 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER NAME: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER NAME: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OPGEN INC CENTRAL INDEX KEY: 0001293818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 061614015 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 708 QUINCE ORCHARD ROAD STREET 2: SUITE 205 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-813-1260 MAIL ADDRESS: STREET 1: 708 QUINCE ORCHARD ROAD STREET 2: SUITE 205 CITY: GAITHERSBURG STATE: MD ZIP: 20878 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2017-12-31 1 0 0 0001293818 OPGEN INC OPGN 0000310158 Merck & Co., Inc. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 0 0 1 0 0000942443 Merck Sharp & Dohme Corp. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 0 0 1 0 0001547132 Merck Global Health Innovation Fund, LLC ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889 0 0 1 0 Warrant to Purchase Common Stock 19.50 2017-06-28 5 A 0 13120 0.00 A 2018-01-28 2022-06-28 Common Stock 13120 13120 I See footnote These amounts reflect the Issuer's recently announced and effectuated a 1 for 25 reverse stock split on January 17, 2018. These securities are owned directly by Merck Global Health Innovation Fund, LLC ("MGHIF"), which is a wholly owned subsidiary of Merck Sharp & Dohme Corp. ("MSD"), which is a wholly owned subsidiary of Merck & Co., Inc. ("Merck"). MSD and Merck are indirect beneficial owners of the reported securities. The reporting person ceased to be a 10% owner on February 7, 2018, as a result of the Issuer's February 7, 2018 public offering. Accordingly, the reporting person is no longer subject to Section 16 in connection with the Issuer and therefore, will no longer report any transaction on Form 4 or Form 5 until such time, if any, that the reporting person becomes a 10% owner again. * Ms. Katie Fedosz is signing as Attorney-in-Fact pursuant to power of attorney dated July 23, 2015 granted by each Reporting Person, a copy of which was filed as an exhibit to Form 3 filed on July 23, 2015 and incorporated herein by reference. /s/Katie Fedosz as Attorney-In-Fact* 2018-02-08